Announcement on Passing GMP Compliance Inspection for Drugs
Filed with SSE · · 2 pages · Chinese
Aurisco Pharmaceutical Co. Ltd. on 6ix
Earlier from Aurisco Pharmaceutical
- Announcement on Result of Shareholding Reduction by Senior Management Members
- Announcement on Obtaining Drug Registration Approval by the Wholly-owned Subsidiary
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Shareholding Reduction Plan for Shareholders
- Announcement on Achieving Conditions for Lifting Sales Restrictions and Listing of the 3rd Restricted Stock Trading Period under the 2022 Restricted Stock Incentive Plan
Later from Aurisco Pharmaceutical
- Announcement on Result of Shareholding Reduction by Shareholder
- Announcement on the Implementation of Repurchase and Cancellation of Partial Restricted Stocks
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Adjusting Upper Limit of Repurchase Price
- Announcement on Implementation Result of Shares Repurchase and Share Changes
Follow Aurisco Pharmaceutical into a list and get an email when it puts out news.
Follow Aurisco Pharmaceutical